The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly
Travel, Accommodations, Expenses - Pfizer; Pfizer
IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER+/HER2- metastatic breast.
 
David Cescon
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; GenomeRx; Gilead Sciences; GlaxoSmithKline; INFLEX; Lilly; Merck; Novartis; Pfizer; Roche/Genentech; SAGA Diagnostics
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Guardant Health (Inst); Inivata (Inst); Knight Therapeutics (Inst); Merck (Inst); Pfizer (Inst); ProteinQure (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent (US62/675,228) for methods of treating cancers characterized by a high expression level of spindle and kinetochore associated complex subunit 3 (ska3) gene.
Expert Testimony - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Inivata/NeoGenomics
 
Moira Rushton
No Relationships to Disclose
 
Nathalie LeVasseur
Honoraria - AstraZeneca; Gilead Sciences; Knight Therapeutics; Lilly; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca Canada; Gilead Sciences; Knight Pharmaceuticals; Lilly; Merck; Novartis; Pfizer; Roche; Tersera; Tersera
Research Funding - AstraZeneca Canada; Exact Sciences; Gilead Sciences; Lilly; Pfizer; Roche Canada
Travel, Accommodations, Expenses - Gilead Sciences
 
Michelle Nadler
Honoraria - Exact Sciences; Novartis
 
Daniel Rayson
Honoraria - Advanced Accelerator Applications; Ipsen; Pfizer
Consulting or Advisory Role - AstraZeneca Canada; Gilead Canada; Ipsen; Lilly; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche Canada
Research Funding - Gilead Sciences (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Brooke Wilson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca Canada; Novartis
Research Funding - Bristol-Mers Squibb (Inst)
 
Sara Taylor
Honoraria - AstraZeneca; Gilead Sciences; Lilly; Novartis Canada Pharmaceuticals Inc; Pfizer
Consulting or Advisory Role - Amgen; Novartis Canada Pharmaceuticals Inc; Roche Canada
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); Mersana (Inst); Novartis Canada Pharmaceuticals Inc (Inst); Regeneron (Inst)
 
Rossanna Pezo
Honoraria - Gilead Sciences; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer/EMD Serono; Seagen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; Gilead Sciences; Lilly; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche; Sanofi
Speakers' Bureau - Novartis Canada Pharmaceuticals Inc
Research Funding - Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Arif Ali Awan
Honoraria - Apotex; AstraZeneca Canada; Exactis Innovation; Lilly; Lilly; Lilly; Novartis; Oncology Education; Roche Canada; Roche Canada
Consulting or Advisory Role - AstraZeneca; AstraZeneca Canada; Exact Sciences; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Lilly; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Pfizer; Pfizer; Roche Canada
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Canexia Health (Inst); Exactis Innovation (Inst); Intensity Therapeutics (Inst); Roche (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Roche/Genentech
 
Vikaash Kumar
Honoraria - Eisai; Ipsen
 
Jen Melvin
Honoraria - AstraZeneca; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Gilead Sciences; Medison; Merck; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Pfizer (Inst); Gilead Sciences (Inst); Merck (Inst); Pfizer (Inst)
 
John Hilton
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Novartis; Pfizer
Research Funding - GlaxoSmithKline (Inst)
 
Stephen Chia
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst)
 
Philippe Bedard
Honoraria - Boehringer Ingelheim
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bicara Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); LegoChem Biosciences (Inst); Lilly (Inst); Medicenna (Inst); Merck (Inst); Novartis (Inst); Sanofi (Inst); Seagen (Inst); Takeda (Inst); Zymeworks (Inst)
(OPTIONAL) Uncompensated Relationships - Janssen Oncology; Lilly; Repare Therapeutics; Roche/Genentech; Seagen; Zymeworks
 
Spencer Finn
No Relationships to Disclose
 
Wei Tu
No Relationships to Disclose
 
Courtney Coschi
Research Funding - AstraZeneca (Inst); Pfizer (Inst)
 
Philippe Jamme
Honoraria - Bristol-Myers Squibb; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Pierre Fabre
 
Elia Aguado-Fraile
Employment - Repare Therapeutics
Stock and Other Ownership Interests - Repare Therapeutics
 
Lesley Seymour
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Repare Therapeutics (Inst)